Skip to content
★ Sign in to follow
JW

Jennie Wilborgsson

Board Director
Membre du Conseil
Ascelia Pharma AB
Total declarations
9
Company
1
▲ Purchases (2 ops.)
€9,417
▼ Sales (0 ops.)
—

Latest filing published 16 Apr 2025 for Ascelia Pharma AB.

Filing timeline

BuySale
Jennie Wilborgsson

Insider track record

Disclosed buys
2
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
2

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Jennie Wilborgsson: trading record in brief

Jennie Wilborgsson, listed as board member, appears in our data through filings on Ascelia Pharma AB shares, published by Finansinspektionen. In total, 9 filings cover trades dated from 29 May 2023 to 15 April 2025.

Purchases make up the whole of the open-market record (2 purchases, €9,417). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 2 share grants.

Most recently, on 16 April 2025, the filings show a transaction in Ascelia Pharma AB. The last purchase on record was published on 21 June 2023, which is 1,236 days ago. The median gap between a trade and its publication by Finansinspektionen is 3 days. The regulation allows three business days to notify a trade (MAR article 19). This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.

Companies and markets linked to Jennie Wilborgsson

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations9 total
  • ●
    Annan medlem i bolagets administrations-, lednings- eller kontrollorganExecutivesAscelia Pharma AB
    0FI-SE
    10,000 shares0WarrantISIN SE0022725438FI:csv-30ab39702b84614961bb
  • ●
    Annan medlem i bolagets administrations-, lednings- eller kontrollorganExecutivesAscelia Pharma AB
    21,500 SEK15FI-SE
    10,000 shares@ SEK 2.150.028% mcap100.0% of flowAktieISIN SE0010573113FI:A003N414-1
  • ◆
    Annan medlem i bolagets administrations-, lednings- eller kontrollorganExecutivesAscelia Pharma AB
    0FI-SE
    440,000 shares0OptionFI:csv-8b6e74c3ebf8b499d70e
  • ●
    Annan ledande befattningshavareExecutivesAscelia Pharma AB
    76,963 SEK0FI-SE
    15,180 shares@ SEK 5.0762.5% of flowBTU (betald tecknad unit)ISIN SE0022725461FI:csv-787b7a6522df3a31497c
  • ●
    Annan ledande befattningshavareExecutivesAscelia Pharma AB
    24,255 SEK0FI-SE
    4,784 shares@ SEK 5.0719.7% of flowBTU (betald tecknad unit)ISIN SE0022725461FI:csv-805e36b0b3c62ce3b812
  • ●
    Annan ledande befattningshavareExecutivesAscelia Pharma AB
    0FI-SE
    7,774 shares0Teckningsrätt/UniträttISIN SE0022725453FI:csv-e67e5069cf1863e1f780
  • ◆
    Annan medlem i bolagets administrations-, lednings- eller kontrollorganExecutivesAscelia Pharma AB
    0FI-SE
    160,000 shares0OptionFI:csv-219072748393dbb02d4b
  • ▲
    Annan medlem i bolagets administrations-, lednings- eller kontrollorganExecutivesAscelia Pharma AB
    59,500 SEK0FI-SE
    3,500 shares@ SEK 17.00AktieISIN SE0010573113FI:csv-9d06fd7fa9f52f06dea0
    Canonical exit: 27 Aug 2023 (T+90)
  • ▲
    Annan medlem i bolagets administrations-, lednings- eller kontrollorganExecutivesAscelia Pharma AB
    49,728 SEK0FI-SE
    2,960 shares@ SEK 16.80AktieISIN SE0010573113FI:csv-f93b962beb2717406454
    Canonical exit: 27 Aug 2023 (T+90)

9 of 9 declarations